Company Overview - Vanda Pharmaceuticals Inc. is a leading global biopharmaceutical company focused on developing and commercializing innovative therapies to address high unmet medical needs and improve patient lives [5]. Upcoming Financial Results - Vanda will release its fourth quarter and full year 2024 financial results on February 13, 2025, after market close [1]. - A conference call will be held on the same day at 4:30 PM ET to discuss the financial results and other corporate activities [2]. Conference Call Details - Participants can join the conference call by dialing 1-800-715-9871 for domestic calls or 1-646-307-1963 for international calls, using passcode 2881765 [2]. - The conference call will be broadcast simultaneously and archived on Vanda's website, with investors advised to register at least 15 minutes early [3]. Replay Information - A replay of the conference call will be available starting at 8:30 PM ET on February 13, 2025, until February 20, 2025, at 11:59 PM ET [4]. - The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers, with the same passcode [4].
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025